Response: Upfront nilotinib therapy among patients with chronic myeloid leukemia in chronic phase.
Expert Opin Pharmacother. 2017 Jan 13;:
Authors: Saydam G
PMID: 28085495 [PubMed - as supplied by publisher]
http://ift.tt/2ji9Wa0
Response: Upfront nilotinib therapy among patients with chronic myeloid leukemia in chronic phase.
Expert Opin Pharmacother. 2017 Jan 13;:
Authors: Saydam G
PMID: 28085495 [PubMed - as supplied by publisher]
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου